Physician

Jeffrey Stewart Rubin, MD

According to 2025 Medicare claims, Jeffrey Rubin, MD (NPI: 1972663656) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. Rubin uses personal NPI as billing NPI and primary practice location at 11229-1173.

Rubin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,495 traditional Medicare patients, billed 50,925 HCPCS/CPT codes, and received $3,360,008 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 2,441 prescription claims across 445 beneficiaries totaling $324,022 in drug costs, led by Prolensa (Bromfenac Sodium). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $211,124 to $324,022. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $1,982,455 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,565,275 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,488,689 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,555,011 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,784,380 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,177,020 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,436,852 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,689,681 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,040,652 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,360,008 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,17913,759$1,982,455
20161,29016,246$2,565,275
20171,28115,741$2,488,689
20181,32915,774$2,555,011
20191,38916,676$2,784,380
20201,14512,547$2,177,020
20211,29815,119$2,436,852
20221,33817,596$2,689,681
20231,40935,897$3,040,652
20241,49550,925$3,360,008

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$204K$407K2015 Drug cost: $211,124 (USD; Tot_Drug_Cst)2016 Drug cost: $228,413 (USD; Tot_Drug_Cst)2017 Drug cost: $254,636 (USD; Tot_Drug_Cst)2018 Drug cost: $293,829 (USD; Tot_Drug_Cst)2019 Drug cost: $377,586 (USD; Tot_Drug_Cst)2020 Drug cost: $348,621 (USD; Tot_Drug_Cst)2021 Drug cost: $259,337 (USD; Tot_Drug_Cst)2022 Drug cost: $317,939 (USD; Tot_Drug_Cst)2023 Drug cost: $407,045 (USD; Tot_Drug_Cst)2024 Drug cost: $324,022 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153321,812$211,124
20163291,826$228,413
20173251,960$254,636
20183562,086$293,829
20193402,163$377,586
20203192,002$348,621
20212961,687$259,337
20223041,839$317,939
20233892,141$407,045
20244452,441$324,022

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7321,703$82
765122d ultrasound scan of eye tissue and structures553648$81
92134Imaging of retina1,4784,604$38
92201Extended exam of the back part of the eye with retinal drawing8841,606$23
92202Extended exam of the back part of the eye with optic nerve drawing6981,706$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium2127,907$98,622
LumiganBimatoprost733,232$32,466
Bromfenac SodiumBromfenac Sodium1224,645$31,436
RestasisCyclosporine371,350$27,352
CombiganBrimonidine Tartrate/Timolol632,448$19,625

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Jeffrey Stewart Rubin, MD?

Tedicare shows public-source Medicare data for Jeffrey Stewart Rubin, MD (NPI 1972663656), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Stewart Rubin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey Stewart Rubin, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Jeffrey Stewart Rubin, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.